15-03-2013

Antiviral Nasal Spray – Data From Two Clinical Studies Prove Effectiveness of Marinomed's Antiviral Drug

 08-03-2013

Marinomed´s Antiviral Nasal Spray Approved für Use in Morocco
Marinomed’s innovative anti-viral nasal spray that has been proven clinically effective against respiratory viruses has now been authorized for the Moroccan market. The product reduces the reproduction and spread of viruses on the nasal mucosa and is based on Marinomed's proprietary technology platform Mavirex®. As a result, Marinomed has now succeeded in licensing the over-the-counter antiviral treatment in a total of 39 countries – while, at the same time, initiating work on the development of new products.

 05-03-2013

Marinomed´s Antiviral Nasal Spray Approved for Use in Canada

 18-12-2012

Guest Comment about startups in Austria for the Austria Press Acency (APA), Dr. Andreas Grassauer, CEO 

 14-12-2012

Escin Inhibits Type I Allergic Dermatitis in a Novel Porcine Model 

 19-11-2012

Marinomed Granted Chinese Patent for Antiviral Polymer

 05-09-2012

Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold

 21-03-2012

Marinomed's Iota-Carrageenan Nasal Spray Achieves Positive Clinical Results Against Common Cold

 12-03-2012

VIDEO Interview Dr. Benjamin Reutterer - interviewed by nawitech (www.nawitech-jobs.at)

 24-11-2011

VIDEO Dr. Eva Prieschl-Grassauer - "Innovationsland Österreich" [YouTube, German]Marinomed has committed itself to increase its research spendings by 20 percent until 2015 at the “Alpbach Technology Forum", an initiative of Doris Bures, Federal Minister for Transport, Innovation and Technology. The signing ceremony of the declaration took place at the reception “Innovationsland Österreich” ["innovation country Austria"] held at the Federal Ministry for Transport, Innovation and Technology.

 31-10-2011 to 
 02-11-2011

Meet Marinomed at: BIO Europe 2011, October 31 - November 2, Düsseldorf, Germany

 27-10-2011

Marinomed Appoints Head of Development

 23-09-2011

INTERVIEW Dr. Eva Prieschl-Grassauer: "In Rekordzeit von der Produktidee zum Markt" ["In record time from product idea to market"] - Dr. Alexandra C. Gruber talks to Dr. Eva Prieschl-Grassauer, Chief Scientific Officer (CSO) of Marinomed Biotechnologie GmbH. Article from PharmAustria 4/2011 www.medmedia.at 

 15-12-2010

Marinomed’s Iota-Carrageenan Effective Against H1N1
Study published in PLoS ONE

 19-11-2010 

Marinomed wins STEP award in "Market/Customer" category and special award for strategic partnerships

 11-08-2010

Marinomed’s Antiviral Effective in Clinical Trial for Common Cold - Study published in Respiratory Research